ID15866A - Turunan-turunan tetrahidroisoquinolin dan penggunaan daripadanya - Google Patents

Turunan-turunan tetrahidroisoquinolin dan penggunaan daripadanya

Info

Publication number
ID15866A
ID15866A IDP970316A ID970316A ID15866A ID 15866 A ID15866 A ID 15866A ID P970316 A IDP970316 A ID P970316A ID 970316 A ID970316 A ID 970316A ID 15866 A ID15866 A ID 15866A
Authority
ID
Indonesia
Prior art keywords
tetrahidroisoquinolin
drivings
tetrahidroisoquinolin drivings
Prior art date
Application number
IDP970316A
Other languages
English (en)
Inventor
Alexander Alanine
Anne Bourson
Bernd Buttelmann
Gunther Fischer
Marie-Paule Heizt Neidhart
Vincent Mutel
Emmanuel Pinard
Stephan Rover
Gerhard Irube
Rene Wyler
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ID15866A publication Critical patent/ID15866A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes
    • C07D221/12Phenanthridines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDP970316A 1996-02-03 1997-02-03 Turunan-turunan tetrahidroisoquinolin dan penggunaan daripadanya ID15866A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96101553 1996-02-03

Publications (1)

Publication Number Publication Date
ID15866A true ID15866A (id) 1997-08-14

Family

ID=8222462

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970316A ID15866A (id) 1996-02-03 1997-02-03 Turunan-turunan tetrahidroisoquinolin dan penggunaan daripadanya

Country Status (29)

Country Link
US (2) US5952344A (id)
JP (1) JP3217290B2 (id)
KR (1) KR100229298B1 (id)
CN (1) CN1167762A (id)
AR (1) AR005613A1 (id)
AU (1) AU723586B2 (id)
BR (1) BR9700816A (id)
CA (1) CA2196392A1 (id)
CO (1) CO4761069A1 (id)
CZ (1) CZ29497A3 (id)
DE (1) DE19703985A1 (id)
ES (1) ES2124672B1 (id)
FR (1) FR2744447B1 (id)
GB (1) GB2309642A (id)
HR (1) HRP970060A2 (id)
HU (1) HUP9700273A1 (id)
ID (1) ID15866A (id)
IL (1) IL120100A (id)
IT (1) IT1289621B1 (id)
MA (1) MA24078A1 (id)
NO (1) NO970431L (id)
NZ (1) NZ314130A (id)
PE (1) PE35698A1 (id)
PL (1) PL318256A1 (id)
SG (1) SG55273A1 (id)
TR (1) TR199700071A2 (id)
TW (1) TW427978B (id)
YU (1) YU3997A (id)
ZA (1) ZA97672B (id)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005506292A (ja) * 2001-03-08 2005-03-03 エモリー ユニバーシティ pHに依存するNMDAレセプターアンタゴニスト
NZ582917A (en) * 2007-06-29 2013-01-25 Univ Emory Nmda receptor antagonists for neuroprotection
JP2012158527A (ja) * 2011-01-31 2012-08-23 Mitsubishi Gas Chemical Co Inc うつ予防

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067203A (en) * 1962-12-04 Tetrahybroisqquinoline derivatives
US3217007A (en) * 1965-11-09 Halo- and nitro-substituted phenethyl-z- methyl tetrahydroisoquinolsnes
NL286505A (id) * 1961-12-15
CH418336A (de) * 1962-02-23 1966-08-15 Hoffmann La Roche Verfahren zur Herstellung von Octahydrophenanthridinverbindungen
US3243438A (en) * 1962-02-23 1966-03-29 Hoffmann La Roche Octahydro phenanthridine compounds
US3480714A (en) * 1966-02-07 1969-11-25 Ciba Geigy Corp N-substituted isoquinolines as antiprotozoal agents
US3361767A (en) * 1966-04-04 1968-01-02 American Home Prod 10, 5(epoxymethano)-10, 11-dihydro-5h-dibenzo[a, d]cyclohepten-13-one and derivatives
GB1386076A (en) * 1971-06-03 1975-03-05 Wyeth John & Brother Ltd Isoquinoline derivatives
US3803151A (en) * 1972-08-23 1974-04-09 Bristol Myers Co Synthesis for the preparation of 3-hydroxy-n-alkylisomorphinans
JPS5291868A (en) * 1976-01-26 1977-08-02 Takeda Chem Ind Ltd Indenopyridine derivatives
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
EP0226511B1 (fr) * 1985-12-13 1989-08-02 LABORATOIRE L. LAFON Société anonyme dite: Dérivés de 5-phényl-1,4,5,6-tétrahydropyrimidine, procédé de préparation et utilisation en thérapeutique
DE68910999T2 (de) * 1988-02-19 1994-03-24 Smithkline Beecham Farma 1,2,3,4-Tetrahydroisoquinoline, Verfharen zu ihrer Herstellung und ihre Verwendung als Kappa-Rezeptor Agonisten.
US5011834A (en) * 1989-04-14 1991-04-30 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon PCP receptor ligands and the use thereof
KR0163355B1 (ko) * 1990-05-10 1998-12-01 알렌 제이. 스피겔 신경보호성 인돌론 및 관련 유도체
US5192751A (en) * 1992-07-24 1993-03-09 Eli Lilly And Company Use of competitive NMDA receptor antagonists in the treatment of urinary incontinence
JPH0741481A (ja) * 1993-05-21 1995-02-10 Hokuriku Seiyaku Co Ltd 両性型三環系化合物
US5389638A (en) * 1993-09-10 1995-02-14 Abbott Laboratories Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake inhibitors
US5439915A (en) * 1994-10-20 1995-08-08 American Home Products Corporation Pyrido[3,4-B]indole carboxamide derivatives as serotonergic agents
US5605906A (en) * 1995-03-24 1997-02-25 Merck Frosst Canada, Inc. Cannabinoid receptor agonists
ZA9610738B (en) * 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof

Also Published As

Publication number Publication date
CN1167762A (zh) 1997-12-17
CA2196392A1 (en) 1997-08-04
HRP970060A2 (en) 1998-04-30
AU1233597A (en) 1997-08-07
PE35698A1 (es) 1998-07-16
ES2124672B1 (es) 1999-11-16
YU3997A (sh) 1999-09-27
US5952344A (en) 1999-09-14
TW427978B (en) 2001-04-01
ITMI970153A1 (it) 1998-07-28
SG55273A1 (en) 1998-12-21
MA24078A1 (fr) 1997-10-01
TR199700071A2 (tr) 1997-08-21
AR005613A1 (es) 1999-06-23
NZ314130A (en) 1998-04-27
PL318256A1 (en) 1997-08-04
IL120100A (en) 2001-01-28
NO970431L (no) 1997-08-04
KR100229298B1 (ko) 1999-11-01
BR9700816A (pt) 1998-07-07
HUP9700273A1 (hu) 1999-08-30
FR2744447A1 (fr) 1997-08-08
CO4761069A1 (es) 1999-04-27
CZ29497A3 (en) 1997-08-13
NO970431D0 (no) 1997-01-31
IL120100A0 (en) 1997-04-15
DE19703985A1 (de) 1997-10-30
GB2309642A (en) 1997-08-06
KR970061871A (ko) 1997-09-12
US6071929A (en) 2000-06-06
IT1289621B1 (it) 1998-10-15
ZA97672B (en) 1997-08-04
GB9702049D0 (en) 1997-03-19
HU9700273D0 (en) 1997-03-28
FR2744447B1 (fr) 2000-09-29
ES2124672A1 (es) 1999-02-01
JP3217290B2 (ja) 2001-10-09
AU723586B2 (en) 2000-08-31
JPH09221474A (ja) 1997-08-26

Similar Documents

Publication Publication Date Title
ID21781A (id) Benzamidoaldehida baru dan penggunaannya
ID19422A (id) Piridina dan bifenil tersubstitusi
ID23684A (id) Komposisi-polimer-organoclay dan pembuatannya
ID24148A (id) Turunan-turunan fitostfrol dan/atau fitostanol
ID24476A (id) Arilsulfonamida dan analognya
ID22426A (id) Ketobenzamida yang baru dan penggunaannya
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
ID17767A (id) Vaksin dan polipeptida-polipeptida sampul hiv
ID19588A (id) Ester dan amida heterosiklik
ID16079A (id) Poliisosianat terblok baru dan penggunaanya
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID22807A (id) Hasil derifat 1-aril dan piridilpirazol untuk pestisida
ID23785A (id) Hidrosianasi diolefin dan isomerisasi 2-alkil-3-monoalkenanitril tak terkonjugasi
ID24524A (id) Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen
ID19833A (id) Aralkil dan aralkilidena heterosiklik laktam dan imida
ID19479A (id) Turunan-turunan amidino baru dan pemakaian sebagai penghambat-penghambat trombin
FR2746328B1 (fr) Gel organomineral de decontamination et son utilisation pour la decontamination de surfaces
ID17089A (id) Perbaikan-perbaikan berkenaan dengan pembersihan perak dan sejenisnya
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID18456A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID17548A (id) Ban dengan ban-dalam dan ban tanpa ban-dalam
ID19147A (id) Ksilanase dan pemakaiannya
ID17199A (id) Mikro-organisme pengurai hidrokarbon yang mengandung halogen dan pemakaiannya
ID18459A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID21847A (id) Komposisi insektisida dan metoda penggunaannya